Inoviq Ltd (AU:IIQ) has released an update.
INOVIQ Ltd has completed a placement of 13.5 million shares and has launched a share purchase plan (SPP) and options prospectus catering to eligible shareholders, offering new shares at $0.50 each and free options exercisable at $1.00, set to commence trading in July. The biotech company specializes in advanced diagnostics and therapeutics for cancer, utilizing its proprietary technologies for exosome isolation and cancer detection. This financial move is anticipated to further fuel INOVIQ’s growth in the healthcare sector.
For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.
